FdaApplication
NDA 204629
Identifiers
- fda_app_no: NDA204629
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2014-08-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JARDIANCE | EMPAGLIFLOZIN | 25MG | TABLET;ORAL |
| JARDIANCE | EMPAGLIFLOZIN | 10MG | TABLET;ORAL |
2 products